- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 131.59M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $358.39M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $357.93M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $304.45M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $305.76M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $274.7M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $268.43M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $645.72M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $636.24M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $938.01M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $911.05M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.24B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.21B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 143.66M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $66.88M |
| Capex | Q1 2025 · Mar 31, 2024 | $177K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $14.81M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $348.88M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $381.08M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.13 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.14 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $32M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $52.92M |
| Net Income | Q1 2025 · Mar 31, 2024 | $18.44M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $13.05M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $146.74M |
| Revenue | Q1 2025 · Mar 31, 2024 | $190.94M |